Abstract
Lung ultrasound is based on the analysis of ultrasound artifacts generated by the pleura and air within the lungs. In recent years, lung ultrasound has emerged as an important alternative for quick evaluation of the patient at the bedside. Several techniques and protocols for performing lung ultrasound have been described in the literature, with the most popular one being the Bedside Lung Ultrasound in Emergency (BLUE) protocol developed, which can be utilized to diagnose the cause of acute dyspnea at the bedside. We attempt to provide a simplified approach to understanding the physics behind the artifacts used in lung ultrasound, the imaging techniques, and the application of the BLUE protocol to diagnose the commonly presenting causes of acute dyspnea.
Traditionally, the role of chest ultrasound in the evaluation of dyspnea was limited to the diagnosis of pleural effusion and guiding interventions like thoracocentesis. Its major drawback was poor penetration of the ultrasound beam due to the overlying thoracic cage and air content within the lung which led to artifacts. The same artifacts were used by Lichtenstein to develop the principles of lung ultrasound. In 1996, Lichtenstein [1] proposed the Bedside Lung Ultrasound in Emergency (BLUE) protocol which was rejected repeatedly, before being finally accepted after 12 years. Today, the principles of the BLUE protocol in lung ultrasound in the critically ill (LUCI) provide a standardized and simplified technique for performing and interpreting lung ultrasound. Lung ultrasound is based on understanding and analyzing the existing acoustic artifacts. It has the advantages of being cost-effective, feasible with bedside availability, lack of ionizing radiation, and allowing real-time imaging. Furthermore, lung ultrasound has a short learning curve and has been found to give reproducible results.
Although the linear transducer is usually used for evaluating the pleura, lung ultrasound is widely performed with convex or micro convex transducers, the latter being preferred if available. The following pictorial review attempts to simplify the physics, technique, interpretation, and pitfalls in performing lung ultrasound. Written informed consent was taken from each patient for publication of images.
Basic knowledge of physics behind the generation of ultrasound artifacts is essential for image interpretation and extrapolation in various lung pathologies. Normally, the transducer emits a short ultrasound pulse which is transmitted into the body and undergoes reflections and scatterings at various levels as it passes through the tissues. The echo signal thus generated, returns to the transducer and is used for image formation. The image formation is dependent on a few basic assumptions [2]: the ultrasound pulse travels in a straight line, the speed of sound in tissues is constant and the depth at which echo is generated is assumed to be determined by the time delay at which the echo signal is received by the probe. These assumptions by the machine form the basis for two of the most important artifacts used in lung ultrasound–A-lines and B-lines (Figure 1) [2,3].
Lungs are voluminous organs, hence detection and localization of pathologies may seem challenging. Various techniques have been described for performing lung ultrasound, the most popular ones being those devised by Lichtenstein [1], Gargani and Volpicelli [4]. These protocols range from comprehensive 28-site scanning evaluation at multiple intercostal spaces in the anterolateral chest wall with/without additional posterior chest evaluation described by Jambrik et al. [5] to the simplified eight-zone scanning of the anterolateral chest wall as described by described by Gargani and Volpicelli [4]. A 14-zone focused thoracic scanning technique (Figure 2) of anterolateral and posterior chest by Laursen et al. [6] has also been described. These techniques are preferred in stable patients. Written informed consent was obtained from each patient for publication of images.
However, in the emergency setup, time is a crucial commodity. One of the principles of LUCI states that life-threatening disorders usually have an extensive projection. On this premise, Lichtenstein [1] defined six BLUE-points, much like the standard electrode placement in electrocardiogram (ECG), allowing a simplified, quick and standardized technique for evaluating a critically ill patient at the bedside. There are three BLUE-points (Figure 3), 2 on the anterior chest wall (upper & lower BLUE point) and 1 located semi posteriorly (posterolateral alveolar and/or pleural syndrome [PLAPS] point). This allows the detection of PLAPS, i.e., consolidation and/or pleural effusion. Although these points are standardized, the protocol allows for operator flexibility. The first step in performing lung ultrasound is localizing the “bat-sign” (Figure 4) [1]. This is an important landmark and must be visualized before analyzing any artifacts.
The BLUE protocol [1] provides lung ultrasound profiles with an algorithmic approach to assist in diagnosis of 6 common acute conditions causing dyspnea: pneumothorax (A’ profile), pneumonia (C profile, AB profile, B’ profile and A-no V-PLAPS profile), pulmonary edema (B profile), acute exacerbation of chronic obstructive pulmonary disease (COPD)/asthma (A-no V-no PLAPS profile), and pulmonary embolism (A-V profile).
The A-profile is defined by the presence of both lung sliding and A-lines on anterior scans, bilaterally. Sometimes one or two B-lines with lung sliding may also be seen and are also included under A-profile. The pleural line is a hyperechoic, nearly horizontal line visualized <1 cm deep to the ribs. It is constituted by the parietal and visceral pleura which are not normally seen separately and indicates the interface between the soft tissues of the chest wall and the lungs. The normal physiological movement of the lungs results in sliding of the visceral pleura against the motionless parietal pleura resulting in a twinkling, to-and-fro motion called “lung sliding” [8]. On M-mode, the “seashore” [8] sign is demonstrated (Figure 5).
The A-profile can be used to diagnose three etiologies of dyspnea (Figure 6). Pulmonary embolism, pneumonia, and COPD/asthma. Firstly, history and clinical examination findings are taken into account while performing a sequential venous analysis to look for thrombosis. If thrombosed veins are visualized, a diagnosis of pulmonary embolism can be suggested. The presence of subpleural consolidations adds to the diagnostic value. If veins are not thrombosed, the PLAPS point is assessed. If pleural effusion and/or consolidation are detected, a diagnosis of pneumonia can be made. In absence of PLAPS, the most likely diagnosis is an acute exacerbation of COPD/asthma (Figure 7).
Zanobetti et al. [9] reported a sensitivity, specificity, positive predictive value, and negative predictive value of 86.8%, 96.1%, 89.7%, and 94.9% for the diagnosis of COPD/asthma by ultrasound. In the extended BLUE protocol [7], the physician performing the scan can extend the BLUE protocol at will and utilize clinical details suggestive of pulmonary embolism e.g. contraceptive pill use, chest pain, hemoptysis, deranged ECG, positive D-dimers, etc. if pulmonary embolism is suspected. Similarly, auscultation to hear wheezing can be done if there is a strong suspicion of COPD/asthma.
The presence of three or more B-lines in one longitudinal scan, disseminated to the anterior chest wall bilaterally with preserved lung sliding is called the B-profile. One must carefully assess a vertical artifact before calling it a B-line. The following are the features of a B-lines (Figure 8) as described by Lichtenstein [7]: (1) B-line is a comet tail artifact. (2) It always arises from the pleural line. (3) Always moves in synchrony with lung sliding. (4) Almost always long, spreading out without fading to edge of the screen. (5) Almost always erases A-lines. (6) Almost always hyperechoic.
Diffuse interstitial syndrome (Figure 9) is an ultrasound diagnosis defined by presence of multiple (three or more) B-lines in more than one scanning zone in the anterolateral chest wall, bilaterally [10]. In the critically ill, diffuse interstitial syndrome is almost always due to pulmonary edema, either hemodynamic (fluid overload or cardiogenic) and permeability induced (acute respiratory distress syndrome [ARDS]/post-infectious, etc.). The utility of B-lines in diagnosis and follow up of Interstitial lung diseases has been established in studies by several authors including Reissig and Kroegel [11], Gargani et al. [12], and Copetti et al. [13]. Reissig and Copetti [14] stated that appearance of the pleural line can be used as a criterion to differentiate pulmonary edema from Interstitial lung disease, with a regular pleural line seen in pulmonary edema. Buda et al. [15] defined several criteria for pulmonary fibrosis on lung ultrasound based on pleural line abnormalities including irregularity, tightening, fragmentary nature, blurring and thickening of the pleura line. Furthermore, Gargani [16] described the utility of lung ultrasound in differentiating pulmonary edema from ARDS on the basis of distribution of B-lines—homogenous, diffuse distribution is seen in pulmonary edema in contrast to non-homogenous distribution with areas of sparing noted in ARDS/acute lung injury. The latter also included additional sonographic findings like pleural alterations and consolidations of varying sizes.
Numerous descriptors are used for B-lines in literature [17], such as “lung rocket” pattern (3 B-lines), “septal rocket” pattern (4 B-lines) representing interlobular septal thickening and “ground glass rocket” pattern (>5 B-lines) representing ground glass areas on computed tomography. Scoring systems [18] have also been devised for semiquantitative assessment of lung aeration depending on number and proximity of B-lines.
This profile is defined by abolished lung sliding at the anterior chest wall with the “A-line” sign. (1) Abolished lung sliding [8]: the presence of air between the parietal and visceral pleura in the case of pneumothorax results in a lack of lung sliding. This is further confirmed using the M-mode tracing which will display horizontal lines above and below the pleural line, known as the “barcode” or “stratosphere sign.” (2) “A-line” sign [17]: this refers to a pattern of exclusive A-lines with a complete absence of B-lines. The loss of B-lines is a result of air accumulating within the pleural space, eliminating the acoustic impedance gradient and thereby hindering the propagation of sound waves.
After establishing the A’ profile, the next step to confirm the diagnosis of pneumothorax is to detect the “lung point” sign (Figure 10) [19], which occurs at the border of pneumothorax due to the sliding lung intermittently coming into contact with the chest wall during inspiration. This is the confirmatory sign for establishing a diagnosis of pneumothorax (Figure 11) and helps in determining its size, which is important for clinical decision-making, as larger pneumothoraces are more likely to require thoracostomy. On M-mode, this sign is translated as alternating “seashore” and “stratosphere” patterns appearing over time when the probe is kept at a particular location. The more lateral or posterior the “lung-point sign” is identified, the larger the pneumothorax. According to Lichtenstein [1], the “Lung-point sign” is 100% specific for pneumothorax but with a relatively low sensitivity of 66% and is not seen in cases of total lung collapse. Various authors [20-22] have found that lung sliding is absent in many cases other than pneumothorax, including pleural effusions, ARDS, large consolidations, pulmonary fibrosis, pleural adhesions, atelectasis, right mainstem intubation, and phrenic nerve paralysis. Thus, lung sliding when used alone has a low specificity.
In the BLUE protocol, the terms used for lung consolidation are “Pneumonia” for anterior consolidation and posterolateral alveolar/pleural syndrome (PLAPS) for consolidation and/or pleural effusion in posterolateral lung zones. In the BLUE protocol [1], pneumonia is diagnosed by four profiles (Figure 12), namely C profile, AB profile, B’ profile and A-no V-PLAPS profile. Anterior consolidation is designated a “C-profile” (Figure 13) while posterolateral consolidation in a patient showing A-profile (lung sliding and A-lines) anteriorly is designated a “A-no V-PLAPS” profile (Figure 14). Unilateral lung-rockets are designated “A/B profile.” Diffuse, bilateral B-lines with loss of lung sliding is designated a “B’ profile.”
Four patterns of consolidation were described by Lichtenstein [1] to diagnose pneumonia. These included “non-translobar consolidation,” “translobar consolidation,” small subpleural consolidation identified by “C-line” and unilateral lung rocket pattern. To identify the “non-translobar” type of consolidation (Figure 15), presence of associated pleural effusion is first looked for by evidence of a regular lung line. This is done to avoid misdiagnosing a consolidation for an effusion. Traditionally, the diagnosis of pleural effusion is based on visualizing an anechoic/hypoechoic collection. This criterion is not advocated by the BLUE protocol, especially in critically ill patients with life-threatening collections like hemothorax and pyothorax and in challenging cases where difficulty in examination might create “parasite echoes” as described by Lichtenstein [7]. In the BLUE protocol, Lichtenstein [1] described the “lung line”, “quad sign” and “sinusoid sign,” as criteria for diagnosis of pleural effusion, disregarding the echogenicity of the collection (Figure 13).
The “Lung line” is a regular line which outlines the effusion, indicating the visceral pleural line, roughly parallel to the pleural line (parietal pleura). Thus, all effusions, anechoic or echoic, can be diagnosed using the lung line. Another useful sign is the “quad sign” which refers to the rough quadrilateral appearance of the effusion framed by the pleural line superiorly, visceral line inferiorly and rib shadows on either side. It is best demonstrated at the “PLAPS point” in a critically ill patient who has to be examined in a supine position.
A dynamic sign for diagnosing pleural effusion is the “sinusoid sign”. On M-mode, a “sinusoidal pattern” is noted due to movement of lung line towards the motionless pleural line on inspiration and downward movement on expiration, shaping a sinusoid. This sign is specific for pleural effusion. However, it is absent in very viscous or septate effusions. Moreover, since this sign indicates a low viscosity of fluid, the use of a narrow-gauge needle for thoracocentesis can be advised.
Apart from detecting pleural effusion, ultrasound can also determine the aeration status of underlying lung. In case of aerated, normal lung, short vertical echogenic lines, called the “Sub-B lines” may be visualized (Figure 13). On the contrary, a shredded margin or frank hepatisation/sonographic bronchograms denote underlying lung consolidation. Furthermore, a quantitative assessment of volume of pleural fluid can also be done using the BLUE-pleural index as highlighted by Lichtenstein [7]. This is done by measuring the interpleural distance at the PLAPS point and applying the correction factor in case of underlying lung consolidation. For example, 3 mm, 1 cm and 2 cm correspond to a “BLUE-pleural volume” of 15–30 ml, 75–150 ml, and 300–600 ml respectively.
Lung ultrasound is a useful imaging modality in the evaluation of dyspnea. With its non-invasive nature, easy availability, and lack of ionizing radiation, ultrasound is capable of diagnosing common respiratory pathologies causing dyspnea including pneumonia, pneumothorax, pulmonary edema, and acute exacerbation of COPD/severe asthma, apart from its traditional use in detecting pleural effusion. It has a short learning curve and when performed with the appropriate technique depending on the clinical scenario, it can assist in arriving at an accurate diagnosis at the bedside, allowing prompt management in critically ill patients.
▪ Lung Ultrasound is a useful tool, especially for bedside diagnosis of dyspnea in the acute and critical care setting.
▪ Lung ultrasound is based on analyzing the ultrasound artifacts generated, and applying the principles of the Bedside Lung Ultrasound in Emergency (BLUE) protocol to arrive at a diagnosis.
▪ Correlation with history and clinical findings at the bedside further adds to the diagnostic value of this quick and feasible technique.
SUPPLEMENTARY MATERIALS
Supplementary materials can be found via https://doi.org/10.4266/acc.2022.00780.
REFERENCES
1. Lichtenstein DA. BLUE protocol and FALLS-protocol: two applications of lung ultrasound in the critically ill. Chest. 2015; 147:1659–70.
3. Baad M, Lu ZF, Reiser I, Paushter D. Clinical significance of US artifacts. Radiographics. 2017; 37:1408–23.
5. Jambrik Z, Monti S, Coppola V, Agricola E, Mottola G, Miniati M, et al. Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol. 2004; 93:1265–70.
6. Laursen CB, Rahman NM, Volpicelli G. Thoracic ultrasound. Lausanne: European Respiratory Society;2018.
7. Lichtenstein D. Lung ultrasound in the critically ill: The BLUE protocol. Switzerland: Springer;2016.
8. Lichtenstein DA, Menu Y. A bedside ultrasound sign ruling out pneumothorax in the critically ill: lung sliding. Chest. 1995; 108:1345–8.
9. Zanobetti M, Scorpiniti M, Gigli C, Nazerian P, Vanni S, Innocenti F, et al. Point-of-care ultrasonography for evaluation of acute dyspnea in the ED. Chest. 2017; 151:1295–301.
10. Volpicelli G, Mussa A, Garofalo G, Cardinale L, Casoli G, Perotto F, et al. Bedside lung ultrasound in the assessment of alveolar-interstitial syndrome. Am J Emerg Med. 2006; 24:689–96.
11. Reissig A, Kroegel C. Transthoracic sonography of diffuse parenchymal lung disease: the role of comet tail artifacts. J Ultrasound Med. 2003; 22:173–80.
12. Gargani L, Doveri M, D'Errico L, Frassi F, Bazzichi ML, Delle Sedie A, et al. Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis. Rheumatology (Oxford). 2009; 48:1382–7.
13. Copetti R, Copetti P, Soldati G. Ultrasound pattern in pulmonary fibrosis: have the vertical artifacts disappeared? Ultrasound Med Biol. 2010; 36:356–7.
14. Reissig A, Copetti R. Lung ultrasound in community-acquired pneumonia and in interstitial lung diseases. Respiration. 2014; 87:179–89.
15. Buda N, Piskunowicz M, Porzezińska M, Kosiak W, Zdrojewski Z. Lung ultrasonography in the evaluation of interstitial lung disease in systemic connective tissue diseases: criteria and severity of pulmonary fibrosis: analysis of 52 patients. Ultraschall Med. 2016; 37:379–85.
17. Lichtenstein D. Whole body ultrasonography in the critically ill. Heidelberg, Berlin, New York: Springer-Verlag;2010.
18. Brusasco C, Santori G, Bruzzo E, Trò R, Robba C, Tavazzi G, et al. Quantitative lung ultrasonography: a putative new algorithm for automatic detection and quantification of B-lines. Crit Care. 2019; 23:288.
19. Lichtenstein D, Mezière G, Biderman P, Gepner A. The "lung point": an ultrasound sign specific to pneumothorax. Intensive Care Med. 2000; 26:1434–40.
20. De Luca C, Valentino M, Rimondi MR, Branchini M, Baleni MC, Barozzi L. Use of chest sonography in acute-care radiology. J Ultrasound. 2008; 11:125–34.
21. Murphy M, Nagdev A, Sisson C. Lack of lung sliding on ultrasound does not always indicate a pneumothorax. Resuscitation. 2008; 77:270.
22. Ball CG, Kirkpatrick AW, Feliciano DV. The occult pneumothorax: what have we learned? Can J Surg. 2009; 52:E173–9.